Biome Australia Ltd (BIO) fair value: what the stock is really worth
As of Oct 5, 2026: fair value of Biome Australia Ltd A$0.18, price A$0.41, upside -55.6%, quality 60 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 4, 2026.
How to read this chart
58‑month range A$0.0610 – A$0.8250 · fair‑value band A$0.1000 – A$0.2200 · the A$0.4050 price screens above the A$0.1800 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 4, 2026.
Follow Biome Australia in your weekly email
Every Wednesday you see whether Biome Australia is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Biome Australia Limited engages in the development, commercialization, and marketing of various live biotherapeutics and complementary medicines in Australia and internationally.
Show more
Biome Australia Limited engages in the development, commercialization, and marketing of various live biotherapeutics and complementary medicines in Australia and internationally. The company provides probiotics as live biotherapeutic products under the Activated Probiotics brand, and nutraceutical and complementary medicines under the Activated Therapeutics brand. It markets its products through community pharmacies, independent health practitioners, and health professionals. The company was incorporated in 2018 and is based in Collingwood, Australia.
Stock analysis
Biome Australia Ltd (BIO) currently trades at A$0.4050, while our model-based Fair Value estimate is A$0.1800, 55.6% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of A$0.7200 per share, and 5 of the 24 models we run sit above the A$0.4050 price.
Bear case: the Asset-Based group reads lowest at A$0.0300, and 19 of the 24 models stay below the price. Evidence for this calculation is low.
Scenario range: A$0.1000 (bear) to A$0.2200 (bull), the price of A$0.4050 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 60/100 (solid quality), in the Consumer Defensive sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Biome Australia Ltd reported revenue of A$23.9M in FY2026 versus A$4.1M in FY2022, a compound +55.2%/yr. Reported net income was A$3.6M in FY2026.
Key figures
Market cap A$92.0M (≈ $63.9M) · P/E ratio 20.3 · P/S ratio 3.06 · EPS (TTM) A$0.0200 · Net margin 15.1% · Return on equity 51.3% · Return on assets (EBIT) −20.2% · Operating margin −0.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (low confidence).
What moves the price
The share trades about 17% below its 52-week high and 80% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at 9% fair-value upside, at −56%, BIO screens richer than that median.
Fair Value models
Bear A$0.1000Fair Value A$0.1800Bull A$0.2200
Price A$0.4050 · Upside -55.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 3 months old). Earnings retained since then (A$0.0053 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.86/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+29.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+48.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+59.4%
Start year 2021 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+80.2%
’19
’20
’21
’22
’23
’24
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−238.3% (2021) → 7.5% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
not computed
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+39.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Australia: IMF forecast 3.0% a year to 2030, 2.9% from 2016 to 2025) that is about +35.6% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 634 stocks
Beats the industry median on 4/12 measures
Overall it trails its industry peers.
Valuation
Quality Score60 · Above median
Fair Value upside−57.1% · Bottom 25%
Profitability
Return on equity (TTM)51.3% · Top 25%
Return on assets2.6% · Below median
Net margin (TTM)15.1% · Top 25%
Operating margin (TTM)−0.4% · Bottom 25%
Growth and dividend
Revenue growth20.2% · Top 25%
Valuation Multiplesvs Packaged Foods median · lower = cheaper
P/E (TTM)20.3× · Pricier than median
P/B7.06× · Priciest 25%
P/S (TTM)2.77× · Priciest 25%
P/FCF46.6× · Priciest 25%
EV/EBITDA85.3× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 35
FUTURE (revenue growth)100· sector 23
PAST (return on equity)100· sector 31
HEALTH (low debt)100· sector 96
DIVIDEND (yield)0· sector 57
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Biome Australia Ltd Fair Value". https://www.fairvalue-calculator.com/stock/BIO.AU
Frequently asked questions
Is Biome Australia Ltd (BIO) overvalued or undervalued?
As of Oct 4, 2026, our model estimates a fair value of A$0.1800 versus a price of A$0.4050, about −56% upside (overvalued).
What is the fair value of BIO?
Our model-based fair value for Biome Australia Ltd is A$0.1800 (as of Oct 4, 2026), built from audited fundamentals. The current price: A$0.4050.
What is the quality score of BIO?
Biome Australia Ltd has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Biome Australia Ltd (BIO)?
Our model-based price target is the fair value of A$0.1800 (as of Oct 4, 2026) from 24 valuation models. Cautious scenario A$0.1000, optimistic scenario A$0.2200. It is a calculation from audited fundamentals, not an analyst target.
What is the Biome Australia Ltd stock forecast for 2026?
Our models put fair value at A$0.1800, about −56% upside versus a price of A$0.4050 (overvalued). Cautious scenario A$0.1000, optimistic scenario A$0.2200. The calculation is refreshed regularly with new filings.
What is the revenue of Biome Australia Ltd (BIO)?
Biome Australia Ltd reported trailing-twelve-month revenue of about A$23.9M (latest available figure, as of Oct 4, 2026).
What growth is priced into Biome Australia Ltd (BIO)?
For today's price to be fair in a discounted-cash-flow model, Biome Australia Ltd would have to grow free cash flow by +39.6 % per year for five years (discount rate 12.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +59.4 % per year. As of Oct 4, 2026.
What discount rate (WACC) does the fair value of BIO use?
Our models discount Biome Australia Ltd at 12.5 %: a base by market capitalisation (micro), damped by beta 0.99, country premium for Australia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Biome Australia Ltd that is +39.6 % per year a year over ten years, using the same discount rate (12.5 %) and the same formula as our fair value.
How much growth has Biome Australia Ltd (BIO) delivered so far?
Over the past 5 years revenue at Biome Australia Ltd grew +59.4 % a year. The price currently implies +39.6 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Biome Australia Ltd (BIO) growing?
The median revenue growth in the sector is +5.2 % a year. That is the yardstick for the growth priced into Biome Australia Ltd (+39.6 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Biome Australia Ltd (BIO)?
The free-cash-flow yield on the price is 1.55 %: that much free cash flow Biome Australia Ltd produces per unit of market value. When it exceeds the discount rate of our models (12.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Biome Australia Ltd (BIO)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Biome Australia Ltd it is A$0.1800 per share (as of Oct 4, 2026), against a price of A$0.4050. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Biome Australia Ltd stock overvalued or undervalued in 2026?
As of Oct 4, 2026, BIO trades above its calculated fair value: price A$0.4050, fair value A$0.1800, a gap of about −56% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BIO?
No. The price is what the market pays today (A$0.4050); the fair value is what the company's own numbers justify (A$0.1800). For Biome Australia Ltd the two are A$0.2250 per share apart. That gap is exactly why we show both numbers side by side.
How much is Biome Australia Ltd worth?
The market values Biome Australia Ltd at about A$92.0M (market capitalisation, as of Oct 4, 2026). Per share that is A$0.4050; our models calculate a fair value of A$0.1800 per share.
What do the bullish and bearish scenarios say about BIO?
Our models span a range for Biome Australia Ltd: cautious scenario A$0.1000, base A$0.1800, optimistic A$0.2200 per share (as of Oct 4, 2026, price A$0.4050). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of BIO?
Biome Australia Ltd trades at a price-to-earnings ratio of 20.3 (as of Oct 4, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of A$0.1800 is built from several models across several years. Other multiples: P/B 7.1, P/S 2.8, EV/EBITDA 85.3.
How solid is the balance sheet of Biome Australia Ltd (BIO)?
Balance-sheet figures for Biome Australia Ltd (as of Oct 4, 2026): return on equity 51.3%. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is BIO from its 52-week high?
Biome Australia Ltd trades at A$0.4050, about 17% below its 52-week high of A$0.4900 and 80% above the low of A$0.2250 (as of Oct 5, 2026). Distance from the high says nothing about value: that is what the fair value of A$0.1800 is for.
Which stocks are comparable to Biome Australia Ltd?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, The Kraft Heinz Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Biome Australia Ltd stock attractive at the current price?
The data as of Oct 4, 2026: price A$0.4050, calculated fair value A$0.1800 (−56%), Quality Score 60/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BIO calculated?
We run Biome Australia Ltd through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of A$0.1800, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0 % above its aggregate fair value. Biome Australia Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Biome Australia Ltd (BIO)?
The closing price on Oct 5, 2026 was A$0.4050. Our model-based fair value is A$0.1800, about −56% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Biome Australia Ltd right now?
The price sits above even our optimistic bull case (A$0.2200). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (A$0.1000 to A$0.2200) leaves room in how you read the outcome.
Key figures of Biome Australia Ltd
How large is the market capitalisation of Biome Australia Ltd (BIO)?
The market capitalisation of Biome Australia Ltd is A$92.0M (≈ $63.9M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Biome Australia Ltd (BIO)?
The price-to-sales ratio of Biome Australia Ltd is 3.06 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Biome Australia Ltd (BIO)?
Earnings per share at Biome Australia Ltd are A$0.0200 (price ÷ EPS = P/E 20.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Biome Australia Ltd (BIO)?
The net margin of Biome Australia Ltd is 15.1% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Biome Australia Ltd (BIO)?
The return on equity (ROE) of Biome Australia Ltd is 51.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Biome Australia Ltd (BIO)?
On an EBIT basis the return on assets of Biome Australia Ltd is −20.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Biome Australia Ltd (BIO)?
The operating margin of Biome Australia Ltd is −0.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Biome Australia Ltd (BIO)?
Revenue at Biome Australia Ltd is growing +20.2% versus a year earlier (3y avg +48.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Biome Australia Ltd (BIO)?
Earnings per share at Biome Australia Ltd are growing +174% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Biome Australia Ltd (BIO) hold?
Biome Australia Ltd holds more cash than debt, A$583K net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Biome Australia Ltd in the live analysis
One click puts Biome Australia Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
